Primary Hyperhidrosis

Author:

Abusailik Mohammad A.,Mustafa Safa M. Bani,Alzboun Habes M.,Al-issa Hussam A.,Oweis Sami W.,Alshudeifat Anas Y.,Nawaiseh Mohammed B.

Abstract

Background: Primary hyperhidrosis (PHH) is characterized by idiopathic, focal, bilateral, and symmetrical excessive and exaggerated sweating with a major impact on the quality of life (QoL). To date, there are no studies about the prevalence of PHH in Jordan and in the Arab region. Aim: To assess the prevalence, severity, and characteristics of PHH in the Jordanian population as well as its impact on QoL. Material and Methods: This study was conducted in five hospitals in Jordan and included 4,500 attendants of outpatient clinics who were evaluated for the presence of PHH. To assess the severity of hyperhidrosis (HH), we used the Hyperhidrosis Disease Severity Scale (HDSS). To evaluate the impact of HH on QoL, the Dermatology Life Quality Index (DLQI) questionnaire was answered by our patients, either digitally or on paper. Results: The overall prevalence of PHH in the Jordanian population was 3.2% (n = 144). The most common site was the axillae (63%), either isolated or in association with other sites. Both sexes were affected equally. The overall mean age of onset was 14.7 years. Positive family history was found in 35% of the patients. Nearly two-thirds of the patients presented with HDSS of 3 or 4. The impact on QoL was substantial with a mean DLQI of 12.8. Conclusion: PHH prevalence in the Jordanian population is 3.2%, which has a major impact on QoL. This raises the need for addressing this disease to reduce its burden on patient lives.

Publisher

Medknow

Reference45 articles.

1. The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis;Cerfolio;Ann Thorac Surg,2011

2. Psychosocial functioning of patients after endoscopic thoracic sympathectomy;Vazquez;Eur J Cardiothorac Surg,2011

3. Botulinum toxin type A is a safe and effective treatment for axillary hyperhidrosis over 16 months: A prospective study;Naumann;Arch Dermatol,2003

4. Current and emerging therapeutic modalities for hyperhidrosis, part 1: Conservative and noninvasive treatments;Ram;Cutis,2007

5. Recognition, diagnosis, and treatment of primary focal hyperhidrosis;Hornberger;J Am Acad Dermatol,2004

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3